| P2093 | author name string | Joel Paris | |
| P2860 | cites work | DSM-5 | Q3064664 |
| | Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration | Q21092366 |
| | Selling sickness: the pharmaceutical industry and disease mongering | Q22242090 |
| | Melancholia and depression during the 19th century: a conceptual history | Q22255569 |
| | Antidepressant drug effects and depression severity: a patient-level meta-analysis | Q24598580 |
| | The endophenotype concept in psychiatry: etymology and strategic intentions | Q28187744 |
| | Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. | Q33994367 |
| | National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 |
| | Extending the bereavement exclusion for major depression to other losses: evidence from the National Comorbidity Survey. | Q34614997 |
| | Major depression prevalence is very high, but the syndrome is a poor proxy for community populations' clinical treatment needs | Q34803350 |
| | How do psychiatric drugs work? | Q35591334 |
| | Validity of the bereavement exclusion to major depression: does the empirical evidence support the proposal to eliminate the exclusion in DSM-5? | Q35698794 |
| | Rethinking recommendations for screening for depression in primary care | Q35794662 |
| | Beyond major depression | Q36108893 |
| | Personality disorder and the outcome of depression: meta-analysis of published studies. | Q36358053 |
| | How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. | Q36610616 |
| | The diagnosis of mental disorders: the problem of reification | Q36917682 |
| | How often do SSRIs and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is low. | Q36940010 |
| | Personality disorder assessments in acute depressive episodes: stability at follow-up | Q37202170 |
| | Placebos in clinical practice: comparing attitudes, beliefs, and patterns of use between academic psychiatrists and nonpsychiatrists | Q37867195 |
| | A case for reprising and redefining melancholia | Q38095086 |
| | The importance and limits of harm in identifying mental disorder. | Q38163671 |
| | Depressive disorders: toward a unified hypothesis | Q39879539 |
| | Definition and epidemiology of treatment-resistant depression | Q41127907 |
| | Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder | Q42537686 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. | Q43292973 |
| | Causal relationship between stressful life events and the onset of major depression | Q44861459 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management | Q45072698 |
| | A longitudinal twin study of personality and major depression in women | Q45090299 |
| | Proportion of antidepressants prescribed without a psychiatric diagnosis is growing | Q46113035 |
| | Basing psychiatric classification on scientific foundation: problems and prospects | Q48251786 |
| | Clinician-identified depression in community settings: concordance with structured-interview diagnoses | Q48491082 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. | Q50733742 |
| | The psychiatric patient's right to effective treatment: implications of Osheroff v. Chestnut Lodge. | Q52058550 |
| | Keeping our eyes on STAR*D | Q80199105 |
| | Is there a delay in the antidepressant effect? A meta-analysis | Q81389466 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | depressive disorder | Q11076418 |
| P304 | page(s) | 148-151 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Canadian Journal of Psychiatry | Q5030253 |
| P1476 | title | The mistreatment of major depressive disorder | |
| P478 | volume | 59 | |